The Surrogacy (Regulation) Act, 2021: A Critique

Asian Bioeth Rev. 2022 Sep 20;15(1):5-18. doi: 10.1007/s41649-022-00222-5. eCollection 2023 Jan.

Abstract

In vitro fertilization (IVF) and surrogacy have enabled many to achieve their dreams of parenthood. With a turnover of $500 million, reproductive tourism in India has helped transform the country into a "global baby factory." However, as the surrogacy industry grew, so did concerns of women's exploitation, commodification of motherhood, and human rights violations. In an effort to prevent women from being exploited, the Indian government had taken successive administrative measures to regulate surrogacy. The Surrogacy (Regulation) Bill, 2016 and Assisted Reproductive Technologies Bill 2008 were introduced in the Parliament to regulate various aspects of surrogacy arrangements. Yet, it was not until 25 January 2022, that the Surrogacy (Regulation) Act, 2021 went into effect. The Act does, however, leave certain important points unaddressed. The article claims that the legislation's purposeful exclusion of the LGBTQ population and emphasis on "familial altruism" stinks of inequity and moral conservatism. It also delineates the mechanics of altruistic surrogacy by examining documents that illustrate how the connections between money and morality are framed via the framing of altruism. The article therefore demands that a comprehensive dialogue must be held considering the socio-economic realities of Indian society, or else India risks enacting yet another law that cannot be implemented or that society dislikes.

Keywords: Altruism; Assisted Reproductive Technology (ART); LGBTQ; Surrogacy.